To help identify the most promising target candidates to bring into a drug discovery partnership, an Internal Target Validation Committee (ITVC) comprised of Baylor faculty has been established.
Chair
Salma Kaochar, Ph.D., MFA
Assistant Professor, Medicine – Hematology & Oncology, Molecular & Cellular Biology, Dan L Duncan Comprehensive Cancer Center
Co-Chair
Damain Young, Ph.D.
Associate Director, Center for Drug Discovery
Assistant Professor, Pharmacology & Chemical Biology and Pathology & Immunology
Blue Square Discoveries Scientific Business Development Director
Committee Members
Malcolm Brenner, M.D., Ph.D.
Professor, Center for Cell & Gene Therapy, Molecular & Human Genetics, Pediatrics, Medicine, Translational Biology & Molecular Medicine
David Nelson, Ph.D.
Professor, Molecular & Human Genetics
Trey Westbrook, Ph.D.
Professor, Molecular & Human Genetics, Biochemistry & Molecular Biology
Director, Therapeutic Innovation Center (THINC)